Patents by Inventor Vinciane Gaussin

Vinciane Gaussin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for the treatment of heart diseases
    Patent number: 10086016
    Abstract: The present invention is related to a pharmaceutical composition comprising cells committed to the generation of heart tissue and at least one pharmaceutically acceptable excipient produced according to internationally recognized standards for pharmaceutical product manufacture, a process for the manufacture of such a pharmaceutical composition and a kit for the administration of said pharmaceutical composition which comprises a container containing said pharmaceutical composition.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: October 2, 2018
    Assignee: CELYAD S.A.
    Inventors: Vinciane Gaussin, Roland Gordon-Beresford, Christian Homsy
  • METHOD FOR DETERMINING THE CARDIO-GENERATIVE POTENTIAL OF MAMMALIAN CELLS
    Publication number: 20160298086
    Abstract: This document is related to a method for determining the cardio-generative potential of mammalian cells which comprises the assessment of a CARdiac generation Potential Index (CARPI) as a function of the quantification of the expression of genes of said cells. It also relates to a method for quantitatively assessing the modification of this cardio-generative potential and the cardiogenic potential of a treatment aiming at cellular differentiation.
    Type: Application
    Filed: June 21, 2016
    Publication date: October 13, 2016
    Inventors: Andre Terzic, Atta Behfar, Roland Gordon-Beresford, Vinciane Gaussin
  • PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEART DISEASES
    Publication number: 20160279168
    Abstract: The present invention is related to a pharmaceutical composition comprising cells committed to the generation of heart tissue and at least one pharmaceutically acceptable excipient produced according to internationally recognized standards for pharmaceutical product manufacture, a process for the manufacture of such a pharmaceutical composition and a kit for the administration of said pharmaceutical composition which comprises a container containing said pharmaceutical composition.
    Type: Application
    Filed: March 4, 2016
    Publication date: September 29, 2016
    Applicant: Celyad S.A.
    Inventors: Vinciane GAUSSIN, Roland Gordon-Beresford, Christian Homsy
  • Pharmaceutical composition for the treatment of heart diseases
    Patent number: 9446076
    Abstract: The present invention is related to a pharmaceutical composition comprising cells committed to the generation of heart tissue and at least one pharmaceutically acceptable excipient produced according to internationally recognized standards for pharmaceutical product manufacture, a process for the manufacture of such a pharmaceutical composition and a kit for the administration of said pharmaceutical composition which comprises a container containing said pharmaceutical composition.
    Type: Grant
    Filed: May 20, 2010
    Date of Patent: September 20, 2016
    Assignee: CARDIO3 BIOSCIENCES S.A.
    Inventors: Vinciane Gaussin, Roland Gordon-Beresford, Christian Homsy
  • PHARMACEUTICAL COMPOSITIONS FOR THE STIMULATION OF STEM CELLS
    Publication number: 20120301538
    Abstract: The invention relates to a human or veterinary pharmaceutical composition (B) for the stimulation of stem cells, comprising at least two stem-cells-stimulating-agents and at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: May 31, 2012
    Publication date: November 29, 2012
    Inventors: Roland GORDON-BERESFORD, Vinciane Gaussin, Jean-Pierre Latere Dwan'isa, Christian Homsy
  • PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEART DISEASES
    Publication number: 20120128638
    Abstract: The present invention is related to a pharmaceutical composition comprising cells committed to the generation of heart tissue and at least one pharmaceutically acceptable excipient produced according to internationally recognized standards for pharmaceutical product manufacture, a process for the manufacture of such a pharmaceutical composition and a kit for the administration of said pharmaceutical composition which comprises a container containing said pharmaceutical composition.
    Type: Application
    Filed: May 20, 2010
    Publication date: May 24, 2012
    Applicant: CARDIO3 BIOSCIENCES S.A.
    Inventors: Vinciane Gaussin, Roland Gordon-Beresford, Christian Homsy
  • METHOD FOR DETERMINING THE CARDIO-GENERATIVE POTENTIAL OF MAMMALIAN CELLS
    Publication number: 20120100533
    Abstract: This document is related to a method for determining the cardio-generative potential of mammalian cells which comprises the assessment of a CARdiac generation Potential Index (CARPI) as a function of the quantification of the expression of genes of said cells. It also relates to a method for quantitatively assessing the modification of this cardio-generative potential and the cardiogenic potential of a treatment aiming at cellular differentiation.
    Type: Application
    Filed: May 20, 2010
    Publication date: April 26, 2012
    Applicants: CARDIO3 BIOSCIENCES SA, MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Andre Terzic, Atta Behfar, Roland Gordon-Beresford, Vinciane Gaussin, Christian Homsy